Medline Inc. (MDLN)

NASDAQ: MDLN · Real-Time Price · USD
47.64
+0.70 (1.49%)
At close: Apr 17, 2026, 4:00 PM EDT
47.09
-0.55 (-1.15%)
After-hours: Apr 17, 2026, 7:53 PM EDT
Market Cap62.58B
Revenue (ttm)28.43B +11.5%
Net Income1.16B -3.4%
EPS1.43 +1,982.8%
Shares Out 1.31B
PE Ratio33.29
Forward PE32.41
Dividendn/a
Ex-Dividend Daten/a
Volume7,076,209
Open47.60
Previous Close46.94
Day's Range47.27 - 48.61
52-Week Range34.89 - 50.88
Betan/a
AnalystsStrong Buy
Price Target50.48 (+5.96%)
Earnings DateMay 6, 2026

About MDLN

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam g... [Read more]

Sector Healthcare
IPO Date Dec 17, 2025
Employees 45,000
Stock Exchange NASDAQ
Ticker Symbol MDLN
Full Company Profile

Financial Performance

In 2025, Medline's revenue was $28.43 billion, an increase of 11.47% compared to the previous year's $25.51 billion. Earnings were $1.16 billion, a decrease of -3.42%.

Financial Statements

Analyst Summary

According to 23 analysts, the average rating for MDLN stock is "Strong Buy." The 12-month stock price target is $50.48, which is an increase of 5.96% from the latest price.

Price Target
$50.48
(5.96% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Medline announces first-in-healthcare AI robotics partnership with Symbotic

Continued investment in next-gen supply chain technology powers Medline's distribution capabilities NORTHFIELD, Ill., April 16, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN) announced a strategic agreem...

1 day ago - PRNewsWire

US FDA warns Medline over defective heart procedure syringes

The U.S. Food and Drug Administration has warned medical device maker Medline that its syringes used in heart procedures are defective and that the ​company has failed to fix the problem adequately.

9 days ago - Reuters

Medline to report first quarter 2026 results on May 6, 2026

NORTHFIELD, Ill., April 08, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report first quarter 2026 financial results on Wednesday, May 6, 2026.

10 days ago - GlobeNewsWire

Medline launches custom product fulfillment technology called Pick Pack Pro™

Investment in combined robotic, conveyor and packing technology supports the delivery of medical supplies directly to homes of health plan members  NORTHFIELD, Ill., April 6, 2026 /PRNewswire/ -- Medl...

11 days ago - PRNewsWire

Medline recognizes manufacturing facilities with Golden Cone Safety Award

NORTHFIELD, Ill., April 3, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN), the largest provider of medical-surgical products and supply chain solutions serving all points of care, announced this week its...

14 days ago - PRNewsWire

Medline receives HIRC Member Choice Awards for supply chain achievement and renews Transparency Badge distinction

Awards selection is highest recognition for healthcare supply chain partnership NORTHFIELD, Ill., April 1, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN), the largest provider of medical-surgical product...

16 days ago - PRNewsWire

Medline's growth continues as it breaks ground on 1.2 million sq. ft distribution center in Midlothian, Texas

Groundbreaking is first operational initiative as a publicly traded company on its continued trajectory of growth NORTHFIELD, Ill., March 11, 2026 /PRNewswire/ -- Medline [Nasdaq: MDLN] announced duri...

5 weeks ago - PRNewsWire

Medline Inc. announces closing of secondary offering of Class A common stock and full exercise of underwriters' option to purchase additional shares

NORTHFIELD, Ill., March 10, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that it has closed its secondary offering of 86,250,000 shares of Medline Inc.'s Class A co...

5 weeks ago - GlobeNewsWire

Medline Awards Distribution Center of the Year and SAFE Awards

NORTHFIELD, Ill., March 9, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN), the largest provider of medical-surgical products and supply chain solutions serving all points of care, announced this week its...

5 weeks ago - PRNewsWire

Medline Inc. announces pricing of secondary offering of class A common stock

NORTHFIELD, Ill., March 04, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today the pricing of a previously announced secondary offering of 75,000,000 shares of Medline In...

6 weeks ago - GlobeNewsWire

Medline Inc. announces launch of secondary offering of Class A common stock

NORTHFIELD, Ill., March 03, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that certain selling stockholders affiliated with Blackstone Inc., The Carlyle Group Inc., ...

6 weeks ago - GlobeNewsWire

Medline Analysts Boost Their Forecasts Following Q4 Results

Medline Inc (NASDAQ: MDLN) reported mixed results for the fourth quarter on Wednesday.

7 weeks ago - Benzinga

Medline Reports Fourth Quarter and Full Year 2025 Results

NORTHFIELD, Ill., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline” or the “Company”) (Nasdaq: MDLN), the largest provider of medical-surgical (“med-surg”) products and supply chain solutions ...

7 weeks ago - GlobeNewsWire

Medline announces participation in the Barclays 28th Annual Global Healthcare Conference

NORTHFIELD, Ill., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, Chief Executive Officer, and Mike Drazin, Chief Financial Officer, are sched...

2 months ago - GlobeNewsWire

Medline to report fourth quarter and full year 2025 results on February 25, 2026

NORTHFIELD, Ill., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report fourth quarter and full year 2025 financial results on Wednesday, Fe...

2 months ago - GlobeNewsWire

Analysts Say Medline Has The Secret Sauce For Sustained Growth

Several analysts initiated coverage on Medline Inc. (NASDAQ: MDLN) on Monday, one of the largest providers of medical-surgical products and supply chain solutions.

3 months ago - Benzinga

Analysts initiate Medline with bullish ratings after blockbuster IPO

Brokerages began coverage of Medline with largely bullish ratings on Monday, betting on supply chain strength and brand penetration, following the firm's upsized U.S. initial public offering in Decemb...

3 months ago - Reuters

Medline Announces Participation in J.P. Morgan 2026 Healthcare Conference

NORTHFIELD, Ill., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, Chief Executive Officer, and Mike Drazin, Chief Financial Officer, are sched...

3 months ago - GlobeNewsWire

The Score: Medline, Tesla, Warner, Trump Media and More Stocks That Defined the Week

Here are some of the major companies whose stocks moved on the week's news.

Other symbols: DJTTSLAWBD
4 months ago - WSJ

Medline Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

NORTHFIELD, Ill., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that it has closed its upsized initial public offering of 248,439,654 shares of its Class A ...

4 months ago - GlobeNewsWire

Trump defends economy, CPI report returns, monster Medline IPO, and more in Morning Squawk

President Donald Trump defended the U.S. economy and blamed his predecessor. "I inherited a mess," he said.

4 months ago - CNBC

Medline's IPO was the largest we've seen in over four years, says Jim Cramer

'Mad Money' host Jim Cramer breaks down Medline's IPO.

4 months ago - CNBC Television

Medline stock is a little too expensive to buy post IPO, Jim Cramer says

CNBC's Jim Cramer reviewed Medline, a medical supplies giant that made its market debut Wednesday. He said he'd wait for a pullback to buy the stock after shares soared more than 41%.

4 months ago - CNBC

Medline's IPO underscores broad investor appetite for a sleepy corner of the healthcare business

Medline's stock soared more than 40% above its IPO price on Wednesday, its first day of trading.

4 months ago - Market Watch

Medline shares surge 30% — worth $46B in Wall Street's biggest IPO of the year

Northfield, Illinois-based Medline, founded in 1966, is a key manufacturer and distributor of medical supplies such as surgical kits, gloves and gowns used by hospitals worldwide.

4 months ago - New York Post